ProductUse cases
Learn
BlogAnalyses, trends & playbooks GuidesIn-depth market guides
PricingFAQ
DE · EN · FR · IT · ES · ROStart now

EFSA Claims That Support Supplement Marketing · Chapter 1 of 7 · 5 min read

The Claim as a Positioning Asset

Two products can contain exactly the same formula and say completely different things about it. One writes "supports the normal function of the immune system" — a phrase backed by an authorised claim, usable within its conditions of use. The other writes "boosts your immunity and shields you from colds" — a phrase that sounds better, rests on no wording in the register, and lives on the hope that nobody is looking.

The difference between the two is not one of copywriting. It's one of architecture: the first brand built its product starting from what it can legally promise; the second built the product and improvised the promise afterwards. This chapter lays the foundation of the whole guide: the claim is not a box to tick at the end — it's an asset chosen at the start, together with the formula.

What you'll be able to do after this chapter

  • distinguish the four layers of a promise: the ingredient, the mechanism, the benefit, the legal claim;
  • understand the real map of the EU register: what's authorised, what's "on hold", what's refused — and why the difference matters commercially, not just legally;
  • know exactly what RavenBI gives you in this territory and where the specialist's work begins.

The principle

A marketing promise for a supplement has four layers, and confusing them is the source of most problems:

  1. The ingredient — what the product contains. Not a promise; a list.
  2. The mechanism — how it would work. Interesting in copy, but not a consumer-verifiable promise either.
  3. The benefit — what changes in the customer's life. This is where selling happens.
  4. The claim — the wording of the benefit the law lets you use. This is where what you sell gets defended.

The EU register divides this fourth layer into territories with very different commercial value. Authorised claims — health claims authorised in the EU, assessed by EFSA and included in the EU register (Regulation 432/2012) — are approved wordings, usable on labels and in ads within their conditions of use — and the list is surprisingly short: only 93 substances have an authorised claim, nearly all vitamins and minerals. "On hold" claims cover botanicals — their evaluation has been suspended in the EU since 2010, and the transitional regime permits their use, subject to the general EU requirements and to each market's rules and practice (one more reason for the specialist's check); much of the market communicates on them, but they remain more open to challenge than an authorised claim used correctly — which itself doesn't excuse you from verifying conditions and context. Refused claims are the closed territory.

The strategic consequence the whole guide rests on: because almost no hero ingredient (the botanicals, the extracts, the differentiators) has an authorised claim of its own, the solid claim is obtained through the construction of the formula — the hero ingredient brings the differentiation, and the carriers with authorised claims bring a promise grounded in the register, usable within its conditions. Chapter 3 turns this into a method.

One thing worth stating explicitly, because it's RavenBI doctrine: the platform shows you the register, links claims to ingredients and to the market, and shows you who communicates on what. It does not perform final legal validation — the exact wording on your label, in the market's language, with conditions of use verified, goes through a compliance specialist before publication. What you gain from the guide is that this conversation takes an hour, not a quarter.

The workflow in RavenBI

  1. Open Ingredients on your market and look at the Claims column: for each ingredient you see at a glance how many claims it has in the register — green means there are authorised claims to build on.
  2. Pick three ingredients you know well — a vitamin, a mineral, a botanical — and open their pages: the Regulatory & EFSA section shows each one's situation.
  3. Notice the pattern that defines the market: vitamins and minerals have authorised claims; botanicals have "on hold" claims or nothing. This is the asymmetry the rest of the guide turns into strategy.
  4. For your current (or planned) product, write down the four layers: what it contains, how it works, what benefit you promise, and — separately, honestly — which legal claim the promise rests on. The gap between line 3 and line 4 is exactly what this guide will close.

How to read the signals

  • Ingredient with authorised claims (green in the list) = material for a direct promise — the approved wording can be used, within its conditions of use.
  • Ingredient with "on hold" claims = walkable but more fragile ground — the market communicates on it, you can too, but differentiation through solidity remains open for someone else to take.
  • Ingredient with nothing in the register = a direct promise on that ingredient has no support — the benefit is built through carriers (chapter 3) or not promised at all.
  • Competitor promising beyond any existing claim = not proof that "it's possible" — only proof that someone is taking a risk you are not obliged to copy.

The typical mistakes

  • treating the claim as an end-of-project problem — once the formula is closed and the label designed, the legal options have already narrowed;
  • confusing "I see this claim everywhere in the market" with "this claim is authorised" — omnipresence signals at most the transitional regime, not solidity;
  • reading the list of 93 substances as bad news — it's exactly the opposite: the scarcity of authorised claims is what makes correct formula construction a differentiator;
  • asking an intelligence tool for a legal verdict — neither RavenBI nor this guide replaces the specialist; they just make using one much cheaper.

Exercise

Take your main product (or your most advanced project) and fill in the four-layer table: ingredient / mechanism / promised benefit / legal claim it rests on. Then answer one question in writing: is your central promise covered by an authorised claim, an "on hold" one, or nothing? The answer tells you which chapter of this guide will be most valuable to you.

To choose claims, you first need to see the register — not as a 400-page PDF, but as a filterable radar tied to your market. Next chapter: navigating the EFSA Radar.

Guide overview